Kulikov A V, Kolpakov V G, Maslova G B, Kozintsev I, Popova N K
Institute of Cytology and Genetics, Russian Academy of Sciences, Novosibirsk.
Psychopharmacology (Berl). 1994 Feb;114(1):172-4. doi: 10.1007/BF02245460.
The effects of the selective 5-HT1A agonists 8-OH-DPAT and flesinoxan and the selective 5-HT2 antagonists ritanserin and ketanserin on immobility time in rats bred for predisposition to catalepsy have been studied. Treatment with 8-OH-DPAT as well as flesinoxan caused a marked dose-dependent decrease in immobility time. Ritanserin and ketanserin did not affect immobility time at any dose tested. It was suggested that 5HT1A rather than 5-HT2 serotonin receptors are involved in the catalepsy and that an hereditary predisposition to catalepsy may be the result of an inherited alteration in 5-HT1A receptors.